Dengue Fever (DBCOND0030502)

Identifiers

Synonyms
Dengue / Dengue fever / Dengue fever virus reinfection / Dengue virus reinfection / Dengue (disorder) / Dengue fever virus infection / Dengue fever [classical dengue]

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05321264
Educational Intervention to Promote Control Behaviors and Prevention of DengueNo drug interventionspreventionNot Availablecompleted
NCT01843621
A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive ChildrenNo drug interventionsprevention1 / 2completed
NCT00849602
The Effect of Chloroquine in the Treatment of Patients With DengueNo drug interventionstreatment1 / 2unknown_status
NCT05268302
Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4)No drug interventionsbasic_science1completed
NCT02833584
Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in AdultsNo drug interventionstreatmentNot Availablecompleted
NCT04133987
Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwanprevention2completed
NCT02332733
Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in ThailandNo drug interventionsprevention2completed
NCT00377754
Prospective Study of Infant DengueNo drug interventionsNot AvailableNot Availableunknown_status
NCT03465254
Dengue Serostatus Study in the PhilippinesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01110551
Tetravalent Chimeric Dengue Vaccine Trialprevention1completed
NCT04377451
Metformin in Dengue With Obesitytreatment1 / 2completed
NCT05919277
A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos AiresNo drug interventionsNot AvailableNot Availablerecruiting
NCT00239577
A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adultsprevention2completed
NCT05661877
Effectiveness of a Online Education Material to Improve Dengue Knowledge and Health-Seeking IntentionNo drug interventionsotherNot Availablenot_yet_recruiting
NCT02766088
This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast AsiaNo drug interventionsotherNot Availableterminated
NCT03612609
Pilot Study to Detect DENGUE Virus in SpermNo drug interventionsbasic_scienceNot Availablecompleted
NCT06255509
Dengue Virus Infection Amongst Patients With Acute Febrile IllnessNo drug interventionsNot AvailableNot Availablerecruiting
NCT03960385
Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - BrazilNot AvailableNot Availablecompleted
NCT03055585
Applying Wolbachia to Eliminate DengueNo drug interventionspreventionNot Availableterminated
NCT02435615
Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue DiagnosisNo drug interventionsdiagnosticNot Availableterminated
NCT00350337
Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US AdultsNo drug interventionsprevention2completed
NCT03799237
Combating Dengue With Innovative, Paradigm-shift-Strategies: Early Dengue Surveillance in Adult Aedes MosquitoesNo drug interventionspreventionNot Availableunknown_status
NCT06109532
Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation.No drug interventionsNot AvailableNot Availablerecruiting
NCT02433652
Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2prevention1completed
NCT02317900
Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy AdultsNo drug interventionsprevention1completed
NCT05048875
An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 ChallengeNo drug interventionstreatment2recruiting
NCT02831699
The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in MexicoNo drug interventionsNot AvailableNot Availablecompleted
NCT00322049
A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive InfantsNo drug interventionsprevention1 / 2completed
NCT01391819
Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian ChildrenNo drug interventionsotherNot Availablecompleted
NCT03631719
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, ColombiaNo drug interventionsNot AvailableNot Availablecompleted
NCT01411241
Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlersprevention3completed
NCT00883441
Implementation Research of New Dengue Vector Control ToolsNo drug interventionshealth_services_researchNot Availablecompleted
NCT05893134
Identification of Risk Determinants of Dengue Transmission Through Landscape AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT05710224
Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan-DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181-002)No drug interventionsprevention2active_not_recruiting
NCT03632486
Bedside Ultrasound Predicts Progression of Severity of Disease in Dengue FeverNo drug interventionsNot AvailableNot Availablecompleted
NCT05366439
Study of AT-752 in Healthy Subjects in a Dengue Human Challenge ModelNo drug interventionstreatment1terminated
NCT03641339
Defining Skin Immunity of a Bite of Key Insect Vectors in HumansNo drug interventionsbasic_scienceNot Availablecompleted
NCT04673422
Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patientstreatment2 / 3completed
NCT05050825
Validation of a CDSA Strategy to Reduce Antibiotic Prescription in SenegalNo drug interventionsdiagnosticNot Availableunknown_status
NCT05688748
Effectiveness Evaluation of a Dengue Self-monitoring SystemNo drug interventionssupportive_careNot Availablecompleted
NCT04786457
ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)No drug interventionsbasic_science1completed
NCT05476757
Safety, Virological and Immunological Assessment of Live Attenuated Dengue Serotype 2 rDEN2delta30-7169.No drug interventionsother0not_yet_recruiting
NCT00375726
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy AdultsNo drug interventionsprevention1completed
NCT02879266
Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of AgeNo drug interventionsprevention1completed
NCT01656174
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red CrossNo drug interventionsNot AvailableNot Availablecompleted
NCT04063774
Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in ColombiaNo drug interventionsdiagnosticNot Availablecompleted
NCT03883620
Safety Study of Dengushield in Healthy AdultsNo drug interventionstreatment1completed
NCT02016027
Pharmacological Effect of Carica Papaya Leaves Mother Tincture in Healthy Individuals Blood ParameterNo drug interventionstreatment1unknown_status
NCT01096576
A Study of Balapiravir in Patients With Dengue Virus Infectiontreatment1completed
NCT03869060
Expansion of a Dengue-1 Live Virus Human ChallengeNo drug interventionsother1completed
NCT06268691
Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal CoatingNo drug interventionspreventionNot Availablecompleted
NCT01477580
Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)No drug interventionsprevention1completed
NCT04906980
A Study of JNJ-64281802 in Participants With Confirmed Dengue FeverNo drug interventionstreatment2terminated
NCT06551844
Adaptive Dengue Antiviral Platform TrialNo drug interventionstreatment2not_yet_recruiting
NCT01563640
Insecticidal School Uniforms for Dengue Prevention in ThailandNo drug interventionspreventionNot Availableterminated
NCT02421367
Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US AdultsNo drug interventionsprevention1 / 2completed
NCT04935801
A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue VirusNo drug interventionsprevention1completed
NCT01702272
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTSNo drug interventionsNot AvailableNot Availablecompleted
NCT02021968
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy AdultsNo drug interventionsprevention1completed
NCT05611710
Anakinra in Dengue With Hyperinflammation ( AnaDen )No drug interventionstreatment2recruiting
NCT02239614
TDENV PIV and LAV Dengue Prime-boost StrategyNo drug interventionsprevention1completed
NCT05967455
Homologous Re-infection With Dengue 1 or Dengue 3No drug interventionsother1active_not_recruiting
NCT02678455
Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, BangladeshNo drug interventionsprevention2completed
NCT04619823
Virological and Immunological Determinants of Arbovirus Infection in New CaledoniaNo drug interventionsbasic_scienceNot Availablerecruiting
NCT04298138
Dengue 3 Human Infection Model (DENV-3)No drug interventionsother1completed
NCT00712803
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy AdultsNo drug interventionsprevention1completed
NCT01488890
Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineNo drug interventionsprevention2completed
NCT04615364
Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of WolbachiaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05213364
Dengue Vaccine Hesitancy and Acceptance in Endemic Regions of Argentina: Impact of Communication StrategiesNo drug interventionsNot AvailableNot Availableunknown_status
NCT04343521
Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne DiseasesNo drug interventionsprevention3active_not_recruiting
NCT05307484
Effects of a Serious Game on Knowledge, Attitude and Practice in Vector Control and Dengue Prevention Among Adults in Primary CareNo drug interventionspreventionNot Availablecompleted
NCT00938379
Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDRNo drug interventionsprevention3unknown_status
NCT01187433
Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South AmericaNo drug interventionsprevention2completed
NCT05229354
Dengue Controlled Human Infection Model in Dhaka, BangladeshNo drug interventionsprevention2active_not_recruiting
NCT01983553
Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05852977
Study of Dengue in Patients With Autoimmune Diseases During the Epidemics of 2020 and 2021 in Reunion IslandNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04672577
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and MalariaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00290147
Safety and Immunogenicity Study of a Dengue Virus DNA VaccineNo drug interventionsprevention1completed
NCT00993447
Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin AmericaNo drug interventionsprevention2completed
NCT03342898
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in AdultsNo drug interventionsprevention3completed
NCT02684383
Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus VaccineNo drug interventionsprevention1completed
NCT04947111
Serological Study of Dengue and Characterization of Immune Response in Ten Endemic and Non-Endemic Cities in MexicoNo drug interventionsdiagnosticNot Availableunknown_status
NCT01477671
Prospective Dengue Seroprevalence Study in 5 to 10 Year-old ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT00730288
Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsNo drug interventionsprevention2completed
NCT00629356
Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever InfectionNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03341637
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)No drug interventionstreatment3completed
NCT01099852
Cohort of Patients Infected by an ArbovirusNo drug interventionsNot AvailableNot Availablerecruiting
NCT03110952
TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B AdjuvantNo drug interventionsprevention1withdrawn
NCT02134652
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue FeverNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02570152
A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South AsiaNo drug interventionsotherNot Availablecompleted
NCT01782300
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months ApartNo drug interventionsprevention1completed
NCT06006559
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue FeverNo drug interventionstreatment2active_not_recruiting
NCT02372175
Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus StrainNo drug interventionsother1completed
NCT04478370
Characterizing Humoral Immune Response to Mosquito BitesNo drug interventionsbasic_scienceNot Availablerecruiting
NCT01506570
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus VaccineNo drug interventionsprevention1completed
NCT03416036
Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 ChallengeNo drug interventionsprevention1completed
NCT05153018
Population Immunity AgaiNst mosquitO-borne Diseases in VanuatuNo drug interventionsbasic_scienceNot Availablecompleted
NCT03803618
Dengue Effectiveness Study in the PhilippinesNo drug interventionsNot AvailableNot Availablecompleted
NCT02606019
The Use of Biomarkers in Predicting Dengue OutcomeNo drug interventionsNot AvailableNot Availableunknown_status
NCT06121934
Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical TrialNo drug interventionstreatment3completed
NCT01374516
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin AmericaNo drug interventionsprevention3completed
NCT01436396
Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersNo drug interventionsprevention3completed
NCT00473135
Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus VaccineNo drug interventionsprevention1completed
NCT01072786
Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus VaccineNo drug interventionsprevention1completed
NCT01751139
An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in BrazilNo drug interventionsotherNot Availableterminated
NCT01436422
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus VaccineNo drug interventionsprevention1completed
NCT01696422
Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) VaccineNo drug interventionsprevention2unknown_status
NCT02392325
Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy AdultsNo drug interventionsprevention1completed
NCT01943825
Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue VaccineNo drug interventionsprevention2completed
NCT06528457
Study to Examine the Effects of Oral FenretinideNo drug interventionstreatment2not_yet_recruiting
NCT04839757
Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French CaribbeanNo drug interventionsNot AvailableNot Availablerecruiting
NCT04582474
Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina FasoNo drug interventionsdiagnosticNot Availableunknown_status
NCT00370682
A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in ThailandNo drug interventionsprevention2completed
NCT05505682
Impact of Project Wolbachia - Singapore on Dengue IncidenceNo drug interventionspreventionNot Availablerecruiting
NCT04989673
Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French GuianaNo drug interventionsNot AvailableNot Availablecompleted
NCT04722627
Study of AT-752 in Healthy SubjectsNo drug interventionstreatment1completed
NCT01931176
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy AdultsNo drug interventionsprevention1completed
NCT02873260
Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30No drug interventionsprevention1completed
NCT05201794
A Study of JNJ-64281802 for the Prevention of Dengue InfectionNo drug interventionsprevention2recruiting
NCT02406729
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue VaccineNo drug interventionsprevention3active_not_recruiting
NCT01550289
Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in IndiaNo drug interventionsprevention2completed
NCT03485144
A Clinical Study to Evaluate TV003 in Healthy Adults in TaiwanNo drug interventionsprevention2completed
NCT01104740
Dengue Seroprevalence Study in Blood Donors in the French West IndiesNo drug interventionsNot AvailableNot Availablecompleted
NCT00322946
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy AdultsNo drug interventionsprevention1completed
NCT06257810
Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West AfricaNo drug interventionsdiagnostic4completed
NCT04826081
Study on the Risks of Symptomatic Dengue on PregnancyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01373281
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in AsiaNo drug interventionsprevention3completed
NCT02450838
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)No drug interventionsprevention1completed
NCT02510690
Factors Associated With Poor Dengue Outcomes in MalaysiaNo drug interventionsNot AvailableNot Availablecompleted
NCT02948933
Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue VaccineNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01443247
Role of Andi-d in Dengue Fever: a Pilot StudytreatmentNot Availablecompleted
NCT02608047
Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in GuangzhouNo drug interventionsNot AvailableNot Availableunknown_status
NCT02824198
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Scheduleprevention2completed
NCT00094705
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy AdultsNo drug interventionsprevention1completed
NCT04235361
Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRCNo drug interventionsNot AvailableNot Availableunknown_status
NCT00880893
Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singaporeprevention2completed
NCT04514107
A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)No drug interventionspreventionNot Availablerecruiting
NCT03746015
Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune AdultsNo drug interventionsprevention2completed
NCT00384670
A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve ChildrenNo drug interventionsprevention1 / 2completed
NCT01218906
Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in AsiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00946218
Diagnosis and Characterization of Dengue Fever in ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT02992418
Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjectsprevention3terminated
NCT04822441
Prospective Study on the Risks of Dengue Fever for the Fetus.No drug interventionsNot AvailableNot Availableunknown_status
NCT01550016
International Research Consortium on Dengue Risk Assessment, Management, and SurveillanceNo drug interventionsNot AvailableNot Availablecompleted
NCT03999996
Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Doseprevention3completed
NCT01502358
Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Diseaseprevention1completed
NCT01502735
Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue DiseaseNo drug interventionsprevention1completed
NCT01917422
Clinical Specimens Testing Program of Dengue Antigen Detection ReagentsNo drug interventionsNot AvailableNot Availablecompleted
NCT01702857
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)No drug interventionsprevention1completed
NCT02302066
Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participantsprevention2completed
NCT04422782
New Tools for Predicting Capillary Leak Shock During Dengue FeverNo drug interventionsdiagnosticNot Availableunknown_status
NCT01293331
Study of Febrile Illness for Dengue-Endemic Areas in Latin AmericaNo drug interventionsNot AvailableNot Availablecompleted
NCT03423173
Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for DengueNo drug interventionsprevention3completed
NCT02569827
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singaporetreatment1 / 2withdrawn
NCT03875560
IC14 in Adult Patients With Dengue FeverNo drug interventionstreatment2withdrawn
NCT02827162
Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue VaccineNo drug interventionsNot AvailableNot Availablecompleted
NCT00936429
Study of HBV-001 D1 in Healthy AdultsNo drug interventionsprevention1completed
NCT01728792
Impact of SC vs IM Administration of DENVax (TDV) on Safety and ImmunogenicityNo drug interventionsprevention1completed
NCT02628444
Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of AgeNo drug interventionsprevention2completed
NCT04313244
Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 YearsNo drug interventionsprevention3completed
NCT02673840
Ketotifen as a Treatment for Vascular Leakage During Dengue FeverNo drug interventionstreatment4unknown_status
NCT05466240
Study of AT-752 in Patients With Dengue InfectionNo drug interventionstreatment2terminated
NCT05407181
Lymphocyte Count and High Fluorescent Count (HFLC) Correlate With Liver Disorder in Dengue Fever PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT06579755
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)No drug interventionsprevention3not_yet_recruiting
NCT02510638
The Clinical Epidemiology of Hospitalized Dengue Cases in MalaysiaNo drug interventionsNot AvailableNot Availablecompleted
NCT03620487
Detection of Dengue Virus in Plasma of Patients in NepalNo drug interventionsNot AvailableNot Availablecompleted
NCT02193087
Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)No drug interventionsbasic_science2completed
NCT00788151
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsNo drug interventionsprevention2completed
NCT03534245
Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT02425098
Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in SingaporeNo drug interventionsprevention2completed
NCT02741128
Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive AdultsNo drug interventionsprevention2completed
NCT01030211
Adult Dengue Platelet StudyNo drug interventionspreventionNot Availablecompleted
NCT06388785
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in MalaysiaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04597437
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)No drug interventionstreatment2recruiting
NCT01421732
Laboratory Diagnosis and Prognosis of Severe DengueNo drug interventionsNot AvailableNot Availablecompleted
NCT01666652
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy AdultsNo drug interventionsprevention1completed
NCT00270699
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy AdultsNo drug interventionsprevention1completed
NCT01064141
A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the PhilippinesNo drug interventionsprevention2completed
NCT00920517
Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue VaccineNo drug interventionsprevention1completed
NCT00875524
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy SubjectsNo drug interventionsprevention2completed
NCT00468858
A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and ChildrenNo drug interventionsprevention2completed
NCT02979535
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®No drug interventionsprevention3completed
NCT01134263
Study of a Tetravalent Dengue Vaccine in Healthy Adults in AustraliaNo drug interventionsprevention3completed
NCT03771963
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy AdultsNo drug interventionsprevention3completed
NCT01224639
Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue FeverNo drug interventionsprevention1completed
NCT01254422
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in MalaysiaNo drug interventionsprevention3completed
NCT02623725
Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose ScheduleNo drug interventionsprevention2completed
NCT04113330
Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in ColombiaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00842530
Efficacy and Safety of Dengue Vaccine in Healthy ChildrenNo drug interventionsprevention2completed
NCT02993757
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®No drug interventionsprevention3completed
NCT05580731
Evaluation Study of Dengue RDTsNo drug interventionsNot AvailableNot Availablecompleted
NCT00688389
Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever InfectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT00617344
Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the USNo drug interventionsprevention2completed
NCT05218304
Baromètre Santé Adulte 2021-2022No drug interventionsotherNot Availablesuspended
NCT02045069
Efficacy and Safety of Ivermectin Against Dengue InfectionNo drug interventionstreatment2 / 3unknown_status
NCT01619969
Celgosivir as a Treatment Against DengueNo drug interventionstreatment1 / 2completed
NCT04434846
Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and CambodiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00831012
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy AdultsNo drug interventionsprevention1completed
NCT06071481
Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock SyndromeNo drug interventionstreatment2recruiting
NCT01973855
Chinese and Western Medicine Treatment of Fever Associated With Bleeding SymptomsNo drug interventionstreatment2unknown_status
NCT00740155
Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve AdultsNo drug interventionsprevention2completed
NCT00089908
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy AdultsNo drug interventionsprevention1completed